Predictive serum biomarkers of patients with cerebral infarction

References

• Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019 Sep 28;394(10204):1145–1158.
   PubMed Web of Science ®Google Scholar
• Tsushima M, Metoki N, Hagii J, et al. D-dimer and C-reactive protein as potential biomarkers for diagnosis of Trousseau’s syndrome in patients with cerebral embolism. J Stroke Cerebrovasc Dis. 2020 Feb;29(2):104534.
   PubMed Web of Science ®Google Scholar
• Lok DJ, Klip IT, Voors AA, et al. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction. Eur J Heart Fail. 2014 Sep;16(9):958–966.
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Liu E, Morrow DA, et al. Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation. 2005;112(25):3868–3875.
   PubMed Web of Science ®Google Scholar
• Denkert C, Budczies J, Kind T, et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006;66(22):10795–10804.
   PubMed Web of Science ®Google Scholar
• Griffin JL, Shockcor JP. Metabolic profiles of cancer cells. Nat Rev Cancer. 2004;4(7):551–561.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang A, Sun H. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology. 2013;57(5):2072–2077.
   PubMed Web of Science ®Google Scholar
• Yin PY, Zhao XJ, Li QR, et al. Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC/Q-TOF MS). J Proteome Res. 2006 Sep 1;5(9):2135–2143.
   PubMed Web of Science ®Google Scholar
• Kim JY, Park JY, Kim OY, et al. Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res. 2010 9; Sep(9): 4368–4375.
   Web of Science ®Google Scholar
• Nicholson JK, Lindon JC. Systems biology - metabonomics. Nature. 2008 Oct 23;455(7216):1054–1056.
   PubMed Web of Science ®Google Scholar
• Fernie AR, Trethewey RN, Krotzky AJ, et al. Innovation - metabolite profiling: from diagnostics to systems biology. Nat Rev Mol Cell Biol. 2004 Sep;5(9):763–769.
   PubMed Web of Science ®Google Scholar
• Griffin JL, Atherton H, Shockcor J, et al. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011 Nov;8(11):630–643.
   PubMed Web of Science ®Google Scholar
• Yin J, Xie J, Guo X, et al. Plasma metabolic profiling analysis of cyclophosphamide-induced cardiotoxicity using metabolomics coupled with UPLC/Q-TOF-MS and ROC curve. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;15;1033-1034:428–435.
   Web of Science ®Google Scholar
• Yu M, Jia HM, Zhou C, et al. Urinary and fecal metabonomics study of the protective effect of Chaihu-Shu-Gan-San on antibiotic-induced gut microbiota dysbiosis in rats. Sci Rep. 2017 Apr;20(7):46551.
   Web of Science ®Google Scholar
• Horrobin DF, Huang YS. The role of linoleic acid and its metabolites in the lowering of plasma cholesterol and the prevention of cardiovascular disease. Int J Cardiol. 1987 Dec;17(3):241–255.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Sun J, Liang Q, et al. A metabonomic approach applied to predict patients with cerebral infarction. Talanta. 2011 Apr 15;84(2):298–304.
   PubMed Web of Science ®Google Scholar
• Iso H, Sato S, Umemura U, et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke. 2002 Aug;33(8):2086–2093.
   PubMed Web of Science ®Google Scholar
• Huijbregts SC, de Sonneville LM, Licht R, et al. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia. 2002;40(1):7–15.
   PubMed Web of Science ®Google Scholar
• Huijbregts S, de Sonneville L, Licht R, et al. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria. Dev Neuropsychol. 2002;22(2):481–499.
   PubMed Web of Science ®Google Scholar
• Diamond A, Prevor MB, Callender G, et al. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev. 1997;62(4):i–v, 1–208.
   PubMed Web of Science ®Google Scholar
• Greeves LG, Patterson CC, Carson DJ, et al. Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia. Arch Dis Child. 2000 Mar;82(3):216–221.
   PubMed Web of Science ®Google Scholar
• Griffiths PV, Demellweek C, Fay N, et al. Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child. 2000 Mar;82(3):209–215.
   PubMed Web of Science ®Google Scholar
• Poddar R, Rajagopal S, Winter L, et al. A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke. J Cereb Blood Flow Metab. 2019 Jun;39(6):1069–1084.
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001 Nov 30;294(5548):1871–1875.
   PubMed Web of Science ®Google Scholar
• Calder PC. Polyunsaturated fatty acids and inflammatory processes: new twists in an old tale. Biochimie. 2009 Jun;91(6):791–795.
   PubMed Web of Science ®Google Scholar
• Yang HH, Duan JX, Liu SK, et al. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation. Theranostics. 2020;10(11):4749–4761.
   PubMed Web of Science ®Google Scholar
• Fluri F, Grunstein D, Cam E, et al. Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats. Exp Neurol. 2015 Mar;265:142–151.
   PubMed Web of Science ®Google Scholar
• Luo C, Bian X, Zhang Q, et al. Shengui sansheng san ameliorates cerebral energy deficiency via citrate cycle after ischemic stroke. Front Pharmacol. 2019;10:386.
   PubMed Web of Science ®Google Scholar
• Belgardt BF, Bruning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci. 2010 Nov;1212(1):97–113.
   PubMed Web of Science ®Google Scholar
• Wu D, Liu J, Pang X, et al. Palmitic acid exerts pro-inflammatory effects on vascular smooth muscle cells by inducing the expression of C-reactive protein, inducible nitric oxide synthase and tumor necrosis factor-alpha. Int J Mol Med. 2014 Dec;34(6):1706–1712.
   PubMed Web of Science ®Google Scholar
• Huang B, Yang XD, Lamb A, et al. Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal. 2010 Sep;22(9):1282–1290.
   PubMed Web of Science ®Google Scholar
• Wang M, Gui X, Wu L, et al. Amino acid metabolism, lipid metabolism, and oxidative stress are associated with post-stroke depression: a metabonomics study. BMC Neurol. 2020 Jun 20;20(1):250.
   PubMed Web of Science ®Google Scholar